Abstract
Background
Pathogenesis of severe acute pancreatitis is still unclear, which leads to a lack of proper treatment in severe acute pancreatitis therapeutic strategy.
Objective
To investigate the effect of treatment with antioxidant pyrrolidine dithiocarbamate on pancreas injury in rats with severe acute pancreatitis and its possible mechanism.
Methods
A total of 144 male Sprague–Dawley rats were randomly allocated into a sham operation group (n = 48), a severe acute pancreatitis group (n = 48), and a pyrrolidine dithiocarbamate-treated group (n = 48). All the rats were killed at 1, 3, 6, 12, 24, and 48 h after operation. The pancreas histopathologies were observed and serum amylase levels were tested. Meanwhile, the nuclear factor-κB activation, tumor necrosis factor-α levels and high-mobility group box protein-1 expression levels in pancreatic tissue were studied.
Results
Animals receiving pyrrolidine dithiocarbamate had significantly improved pancreas histopathology and lower serum amylase levels (p < 0.05). In the severe acute pancreatitis group, pancreas tumor necrosis factor-α levels reached a peak at 6 h after operation and afterwards rapidly declined to normal levels. However, high-mobility group box protein-1 levels in pancreatic tissue increased remarkably at the 12th hour, reached a peak at 24 h, and maintained up to 48 h post-severe acute pancreatitis. Compared to the severe acute pancreatitis group, the pancreas nuclear factor-κB activity, tumor necrosis factor-α, high-mobility group box protein-1 levels in the pyrrolidine dithiocarbamate-treated group all remarkably decreased (p < 0.05).
Conclusions
High-mobility group box protein-1 seems to act as a late cytokine mediator in the pathogenesis of severe acute pancreatitis. Pyrrolidine dithiocarbamate might inhibit the activation of nuclear factor-κB to blockade tumor necrosis factor-α, thereby indirectly suppressing the high-mobility group box protein-1 and reducing pancreatic tissue damage in rats with severe acute pancreatitis.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-009-1073-0/MediaObjects/10620_2009_1073_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-009-1073-0/MediaObjects/10620_2009_1073_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-009-1073-0/MediaObjects/10620_2009_1073_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-009-1073-0/MediaObjects/10620_2009_1073_Fig4_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10620-009-1073-0/MediaObjects/10620_2009_1073_Fig5_HTML.gif)
Similar content being viewed by others
References
Felderbauer P, Müller C, Bulut K, et al. Pathophysiology and treatment of acute pancreatitis: new therapeutic targets—a ray of hope. Basic Clin Pharmacol Toxicol. 2005;97(6):34350. PMID: 16364048.
Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248–251. PMID: 10398600.
Yasuda T, Ueda T, Takeyama Y, et al. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas. 2006;33(4):359–363. PMID: 17079940.
Li JH, Yu JP, Yu HG, et al. Melatonin reduces inflammatory injury through inhibiting NF-κB activation in rats with colitis. Mediators Inflamm. 2005;2005(4):185–193. PMID: 16192667.
Homaidan FR, Chakroun I, El-Sabban ME. Regulation of nuclear factor-κB in intestinal epithelial cells in a cell model of inflammation. Mediators Inflamm. 2003;12(5):277–283. PMID: 14760934.
Virlos I, Mazzon E, Serraino I, et al. Pyrrolidine dithiocarbamate reduces the severity of cerulean-induced murine acute pancreatitis. Shock. 2003;20(6):544–550. PMID: 14625479.
Satoh A, Shimosegawa T, Fujita M, et al. Inhibition of nuclear factor-kappaB activation improves the survival of rats with taurocholate pancreatitis. Gut. 1999;44(2):253–258. PMID: 9895386.
Aho HJ, Koskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol. 1980;15(4):411–416. PMID: 7433903.
Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992;215(1):44–56. PMID: 1731649.
Norman JG, Fink G, Franz M, et al. Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg. 1996;223(2):163–169. PMID: 8597510.
Laveda R, Martinez J, Munoz C, et al. Different profile of cytokine synthesis according to the severity of acute pancreatitis. World J Gastroenterol. 2005;11(34):5309–5313. PMID: 16149137.
Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high mobility-group chromosomal proteins. Mol Cell Biol. 1999;19(8):5237–5246. PMID: 10409715.
Fiuza C, Bustin M, Talwar S, et al. Inflammation promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003;101(7):2652–2660. PMID: 12456506.
Yu M, Wang H, Ding A, et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock. 2006;26(2):174–179. PMID: 16878026.
Park JS, Gamboni-Robertson F, He Q, et al. High mobility group box 1 protein (HMGB1) interacts with multiple toll like receptors. Am J Physiol Cell Physiol. 2006;290(3):917–924. PMID: 16267105.
Lutz W, Stetkiewicz J. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation. Int J Occup Med Environ Health. 2004;17(2):245–254. PMID: 15387080.
Taniguchi N, Kawahara K, Yone K, et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 2003;48(4):971–981. PMID: 12687539.
Ek M, Popovic K, Harris HE, Nauclér CS, Wahren-Herlenius M. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren’s syndrome. Arthritis Rheum. 2006;54(7):2289–2294. PMID: 16802368.
Udalova IA, Knight JC, Vidal V, Nedospasov SA, Kwiatkowski D. Complex NF-κB interactions at the distal tumor necrosis factor promoter region in human monocytes. J Biol Chem. 1998;273(33):21178–21186. PMID: 9694874.
Algül H, Tando Y, Schneider G, Weidenbach H, Adler G, Schmid RM. Acute experimental pancreatitis and NF-κB/Rel activation. Pancreatology. 2002;2(6):503–509. PMID: 12435862.
Andersson U, Tracey KJ. HMGB1 in sepsis. Scand J Infect Dis. 2003;35(9):577–584. PMID: 14620138.
Bonaldi T, Talamo F, Scaffidi P, et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003;22(20):5551–5560. PMID: 14532127.
Grisham MB. NF- κappaB activation in acute pancreatitis: protective, detrimental, or inconsequential? Gastroenterology. 1999;116(2):489–492. PMID: 9922332.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Z.W., Zhang, Q.Y., Zhou, M.T. et al. Antioxidant Inhibits HMGB1 Expression and Reduces Pancreas Injury in Rats with Severe Acute Pancreatitis. Dig Dis Sci 55, 2529–2536 (2010). https://doi.org/10.1007/s10620-009-1073-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-009-1073-0